Agonist NewsLatest News On Agonist GLP-1 drugs linked to fewer post-surgical complications in diabetic patients People With Diabetes Who W...1/7/2025 3:15 AM Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD1/6/2025 11:47 AM The brain’s hunger switch: TRH neurons hold the key to obesity therapies12/10/2024 1:11 AM Expert explores the expanding applications of GLP1 therapies11/28/2024 3:34 PM GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events11/27/2024 4:30 PM More than half of all US adults are eligible for semaglutide therapy11/20/2024 10:42 AM Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption11/19/2024 10:41 AM GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder11/18/2024 3:56 PM Tirzepatide improves heart health and function in obese HFpEF patients11/18/2024 1:04 PM Growth hormone-releasing hormone transforms therapeutic potential in health and chronic disease11/18/2024 4:34 AM Tirzepatide significantly reduces weight and diabetes risk in patients with obesity and prediabetes11/15/2024 3:30 AM Canadian guideline expands treatment options for opioid use disorder11/12/2024 2:55 PM GLP-1 and SGLT2 inhibitors show promise in preventing recurrent stroke and heart attack11/11/2024 1:53 PM Semaglutide may reduce Alzheimer's risk in diabetics10/25/2024 5:25 PM Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients10/23/2024 4:20 PM Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication10/22/2024 8:35 AM Methadone more effective than buprenorphine in reducing treatment discontinuation10/22/2024 12:29 AM Ozempic and similar drugs may lower risks for opioid and alcohol use disorders10/17/2024 12:22 PM Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models10/15/2024 2:20 AM Semaglutide improves heart health and reduces weight in obese patients, but with side effects10/15/2024 1:53 AM
